Cardiovascular Systems Inc (CSII) Q4 2019 Earnings Call Transcript
CSII earnings call for the period ending June 30, 2019.
Cardiovascular Systems
CSII
CSII
$49.85
$1.55
3.2%
BATS BZX Real Time Price as of August 19, 2019, 4:00 p.m. EDT
View Interactive CSII Charts
Cardiovascular Systems Inc is a medical device company which is focused on developing and commercializing interventional treatment systems for vascular disease.
News & Analysis: Cardiovascular Systems
Cardiovascular Systems Inc (CSII) Q3 2019 Earnings Call Transcript
CSII earnings call for the period ending March 31, 2019.
Cardiovascular Systems Inc (CSII) Q2 2019 Earnings Conference Call Transcript
CSII earnings call for the period ending December 31, 2018.
Why Cardiovascular Systems Inc's Stock Flatlined Today
A revenue miss at the medical-device maker.
Cardiovascular Systems Inc is Crashing Today: Here's Why
Cardiovascular Systems falls hard after reporting preliminary quarterly results. Here's what investors need to know.
Why Cardiovascular Systems Inc is Crashing Today
Cardiovascular Systems stock fell hard today after the company reported revenue results below its guidance range.
Why Cardiovascular Systems, Inc. Shares Are Feeling Pumped
Cardiovascular Systems rockets higher after reporting its second-quarter earnings results. Should shareholders be excited or concerned following this report?
Abiomed, Inc.: The Best Medical Device Companies of 2013
Abiomed's Impella heart pumps are carving out an important niche in cardiac cath labs.
Why Cardiovascular Systems Inc. Shares Were Pumped Up
The Food and Drug Administration gives a thumbs-up to Cardiovascular Systems' revolutionary calcified artery-fighting device.
Why Cardiovascular Systems Shares Surged
Is this meaningful? Or just another movement?
